| Trial Identifier: | D1691R00001 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT03038789 |
| Start Date: | April 2017 |
| Primary Completion Date: | August 2019 |
| Study Completion Date: | August 2019 |
| Condition: | Diabetes: Type 2 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| South Korea | Busan, South Korea |
| South Korea | ChungCheong, South Korea |
| South Korea | DaeGu, South Korea |
| South Korea | DaeJeon, South Korea |
| South Korea | GyeongGi, South Korea |
| South Korea | Jeonbuk, South Korea |
| South Korea | Seoul, South Korea |
| South Korea | SunCheon, South Korea |
| South Korea | WonJu, South Korea |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company